Archived from the original on 30 March 2023
Semaglutide is used as an adjunct therapy to effectively regulate blood glucose levels and is typically prescribed to people who have been diagnosed with type 2 diabetes
The full glycemic effect typically develops over several weeks as the medication reaches steady-state concentrations in the bloodstream
Gastrointestinal side effects are the most common including nausea, vomiting, and diarrhea
BEATRIZ DE LA CALLE Head of Commercial Analytics Qualicaps, Leading Pharmaceutical Company www.qualicaps.com/ We partnered with MarketsandMarkets for an assessment study on hard empty capsules
Applicable Procedure Codes: 20552, 20553, 20605, 20606, 21010, 21050, 21060, 21070, 21085, 21110, 21240, 21242, 21243, 21247, 21299, 29800, 29804, 90901, E0746, E1399, E1700, E1701, E1702